Eye cancer statistics

Cases

New cases of eye cancer, 2015, UK

Deaths

Deaths from eye cancer, 2016, UK

 

Survival

Survive eye cancer for 10 or more years, 2009-2013, England

 

Prevention

Preventable cases of eye cancer, UK

  • There are around 750 new eye cancer cases in the UK every year, that's around 2 every day (2013-2015).
  • Eye cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2015).
  • In males in the UK, eye cancer is not among the 20 most common cancers, with around 390 new cases in 2015.
  • In females in the UK, eye cancer is not among the 20 most common cancers, with around 350 new cases in 2015.
  • Incidence rates for eye cancer in the UK are highest in people aged 80 to 84 (2013-2015).
  • Since the early 1990s, eye cancer incidence rates have increased by around a seventh (14%) in the UK. Rates in males have remained stable, and rates in females have remained stable.
  • Over the last decade, eye cancer incidence rates have increased by a quarter (25%) in the UK. Rates in males have increased by more than a fifth (22%), and rates in females have increased by more than a quarter (28%).
  • Most eye cancers occur in the choroid.
  • An estimated 5,800 people who had previously been diagnosed with eye cancer were alive in the UK at the end of 2010.

See more in-depth eye cancer incidence statistics

  • There are around 110 eye cancer deaths in the UK every year, that's around 2 every week (2014-2016).
  • Eye cancer is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2016).
  • In males in the UK, eye cancer is not among the 20 most common causes of cancer death, with around 60 deaths in 2016.
  • In females in the UK, eye cancer is not among the 20 most common causes of cancer death, with around 50 deaths in 2016.
  • Mortality rates for eye cancer in the UK are highest in people aged 85 to 89 (2014-2016).
  • Since the early 1970s, eye cancer mortality rates have decreased by almost three-fifths (55%) in the UK. Rates in males have decreased by more than half (53%), and rates in females have decreased by almost three-fifths (58%).
  • Over the last decade, eye cancer mortality rates have remained stable in the UK. Rates in males have remained stable, and rates in females have remained stable.

See more in-depth eye cancer mortality statistics

  • 6 in 10 (60%) people diagnosed with eye cancer in England survive their disease for ten years or more (2009-2013).
  • 7 in 10 (70%) people diagnosed with eye cancer in England survive their disease for five years or more (2009-2013).
  • 95% of people diagnosed with eye cancer in England survive their disease for one year or more (2009-2013).
  • Eye cancer 10-year survival in England is similar in men and women (2009-2013).
  • Eye cancer survival in England is highest for adults diagnosed aged under 50 years old (2009-2013).
  • Around 8 in 10 people in England diagnosed with eye cancer aged 15-49 survive their disease for five years or more, compared with almost two-thirds of people diagnosed aged 70-89 (2009-2013).

See more in-depth eye cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 930 UK males and 1 in 1,049 UK females will be diagnosed with eye cancer in their lifetime.

See more in-depth eye cancer risk statistics

  • ‘Two-week wait’, ‘31-day wait’ and ’62-day wait’ standards are met by all countries for brain and CNS tumours.

See more in-depth eye cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

The latest statistics available for eye cancer in the UK are; incidence 2015, mortality 2014 and survival 2009-2013. Risk factors information are in production.

The ICD code for eye cancer is ICD-10 C69.

European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.

Meta-analyses Open a glossary item and systematic reviews Open a glossary item  are cited where available, as they provide the best overview of all available research and most take study quality into account. Individual case-control and cohort studies Open a glossary item are reported where such aggregated data are lacking.

Most cases of eye cancer are in the uvea; accordingly most evidence cited on our risk factors page is for uveal melanoma specifically rather than eye cancer overall. The specific cancer type is stated where possible.

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Eye cancer is part of the group 'Brain and CNS tumours' for cancer waiting times data. Codes vary per country but broadly include: peripheral nerves and autonomic nervous system, eye and adnexa, meninges, brain, spinal cord, cranial nerves and other parts of the CNS, and secondary cancers of brain and cerebral meninges and other and unspecified parts of nervous system.

Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.

Last reviewed:

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 2.3 out of 5 based on 17 votes
Thank you!
We've recently made some changes to the site, tell us what you think